Here's What Key Metrics Tell Us About DexCom (DXCM) Q4 Earnings

Core Insights - DexCom reported $1.11 billion in revenue for Q4 2024, a year-over-year increase of 7.6% [1] - The EPS for the same period was $0.45, down from $0.50 a year ago, indicating a -10.00% surprise compared to the consensus estimate [1] - The revenue met the Zacks Consensus Estimate, showing a slight surprise of +0.05% [1] Revenue Breakdown - International revenue was $310.70 million, exceeding the six-analyst average estimate of $307.38 million, with a year-over-year change of +17.1% [4] - U.S. revenue reached $802.80 million, slightly above the $798.41 million average estimate, reflecting a +4.4% year-over-year change [4] - Hardware revenue was $45 million, below the two-analyst average estimate of $46.55 million, showing a significant year-over-year decline of -48.6% [4] - Revenue from sensors and other products was $1.07 billion, slightly above the $1.06 billion estimate, with a year-over-year increase of +12.8% [4] Stock Performance - DexCom shares returned +4.3% over the past month, outperforming the Zacks S&P 500 composite's +3.9% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]